跳至主要内容
临床试验/CTRI/2023/01/048844
CTRI/2023/01/048844招募中未知

Integrated multi-omics and machine learning to decipher pathobiology and outcomes in alcoholic hepatitis patients

ICMR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients age 18 to 80 years
  • 2. Patients with probable or definite alcoholic hepatitis (AH) (as per AASLD guidelines)
  • will be enrolled from consecutive patients presenting first time to the department.
  • The diagnosis of AH will be made as per the NIAAA consensus, i.e.,
  • onset of jaundice within the prior eight weeks,
  • ongoing consumption of >40g (female) or >60 (male)g of alcohol/day for 6 months or
  • more, with less than 60 days of abstinence before the onset of jaundice
  • aspartate aminotransferase >50, aspartate aminotransferase/alanine aminotransferase
  • >1.5, and both values <400IU/L
  • serum bilirubin (total) >3.0 mg/dL
  • liver biopsy confirmation in patients with confounding factors

排除标准

  • Patients having:
  • i. HIV infection
  • ii. Prior organ transplantation
  • iii. Hepatic or extra-hepatic malignancy
  • iv. Receiving any experimental therapies
  • v. Pregnant or lactating women, will be excluded

研究者

发起方
ICMR

相似试验